ClinVar Miner

Submissions for variant NM_007272.3(CTRC):c.308del (p.Gly103fs)

dbSNP: rs773119534
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000755996 SCV000883690 pathogenic not provided 2017-09-26 criteria provided, single submitter clinical testing The CTRC c.308delG; p.Gly103fs variant (rs773119534) has been reported in a patient with hereditary chronic pancreatitis (Rosendahl 2008) and is only observed on two alleles in the Genome Aggregation Database. This variant introduces a frameshift by deleting a single nucleotide, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered pathogenic. REFERENCES Rosendahl J et al. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet. 2008; 40(1):78-82.
Labcorp Genetics (formerly Invitae), Labcorp RCV000806787 SCV000946805 uncertain significance Hereditary pancreatitis 2022-05-03 criteria provided, single submitter clinical testing This variant is present in population databases (rs773119534, gnomAD 0.008%). This sequence change creates a premature translational stop signal (p.Gly103Valfs*31) in the CTRC gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in CTRC cause disease. This premature translational stop signal has been observed in individual(s) with hereditary pancreatitis (PMID: 18059268, 28502372). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 618049).
Ambry Genetics RCV000806787 SCV002606369 pathogenic Hereditary pancreatitis 2021-09-22 criteria provided, single submitter clinical testing The c.308delG pathogenic mutation, located in coding exon 4 of the CTRC gene, results from a deletion of one nucleotide at nucleotide position 308, causing a translational frameshift with a predicted alternate stop codon (p.G103Vfs*31). This variant was detected in an individual with hereditary chronic pancreatitis; it was not detected in individuals with idiopathic chronic pancreatitis or unaffected controls from the same study (Rosendahl J et al. Nat Genet, 2008 Jan;40:78-82). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.